These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27939577)

  • 1. Utility of the Roche Cobas 4800 for detection of high-risk human papillomavirus in formalin-fixed paraffin-embedded oropharyngeal squamous cell carcinoma.
    Pettus JR; Wilson TL; Steinmetz HB; Lefferts JA; Tafe LJ
    Exp Mol Pathol; 2017 Feb; 102(1):47-49. PubMed ID: 27939577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 System.
    Kerr DA; Sweeney B; Arpin RN; Ring M; Pitman MB; Wilbur DC; Faquin WC
    Arch Pathol Lab Med; 2016 Aug; 140(8):844-8. PubMed ID: 27031775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
    Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the Roche Cobas® HPV 4800 in Formalin-Fixed, Paraffin-Embedded Samples for Head and Neck Squamous Cell Carcinomas.
    Zhou W; Rowe L; Witt B; Deftereos G
    Head Neck Pathol; 2021 Jun; 15(2):532-536. PubMed ID: 33128730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
    Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
    Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop mediated isothermal amplification (LAMP) for the detection and subtyping of human papillomaviruses (HPV) in oropharyngeal squamous cell carcinoma (OPSCC).
    Livingstone DM; Rohatensky M; Mintchev P; Nakoneshny SC; Demetrick DJ; van Marle G; Dort JC
    J Clin Virol; 2016 Feb; 75():37-41. PubMed ID: 26780110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
    Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.
    Mendez-Pena JE; Sadow PM; Nose V; Hoang MP
    Hum Pathol; 2017 May; 63():184-189. PubMed ID: 28302536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an E6/E7 PCR-capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer.
    Yin J; Li Y; Song C; Liu Y; Zhao J; Zhao D; Zhang S; Zhang X; Zhao F; Qiao Y
    J Med Virol; 2024 Jun; 96(6):e29716. PubMed ID: 38818787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
    Huho AN; Yadak N; Bocklage TJ; Yang S
    J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
    Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.
    Schache AG; Liloglou T; Risk JM; Jones TM; Ma XJ; Wang H; Bui S; Luo Y; Sloan P; Shaw RJ; Robinson M
    Br J Cancer; 2013 Apr; 108(6):1332-9. PubMed ID: 23412100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.